EVP, U.S. oncology, Novartis
By Tom Kendris, president, Novartis Corp. and U.S. country president
It is an honor and pleasure to be among the first to congratulate Bill Hinshaw on this distinguished honor. Bill’s passion for transforming cancer care to improve and extend the lives of cancer patients inspires all of us at Novartis and reminds us why we come to work each day.
I have had the pleasure of knowing and working with Bill for more than 10 years. He is a key member of my Novartis U.S. country executive committee, and we work closely together on many important policy issues. Bill’s focus on clinical innovation and providing meaningful value-based care has helped Novartis push the boundaries of science to deliver breakthrough treatments while working across the healthcare system to provide better outcomes and positively shape the patient journey for cancer patients.
Bill is committed to leading in this moment of time where advances in science, data, and technology give us the opportunity to optimize cancer care more than ever. He believes innovation thrives on curiosity and the purpose to see it through, and uses this to motivate his team to think differently about how to tackle the most pressing healthcare issues.
Bill is truly one of the most influential leaders in the healthcare industry. He is an inspiring leader whose motivation is driven by reminding himself and his teams that every patient and every day matters.